POP-OUT | CLOSE
 
 
11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE
 
NVP is found in 21 entries
NVP
  •   Chemical Component Summary   Hide
    Name 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE
    Identifiers 11-cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
    Synonyms NON-NUCLEOSIDE RT INHIBITOR NEVIRAPINE
    Formula C15 H14 N4 O
    Molecular Weight 266.30 g/mol
    Type non-polymer
    Isomeric SMILES
    InChI
    InChI key NQDJXKOVJZTUJA-UHFFFAOYSA-N
     
  •   Drug Info: DrugBank Hide
    DrugBank ID DB00238   (Stereoisomeric match)
    Name Nevirapine
    Groups approved
    Description A potent, non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with nucleoside analogues for treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection and AIDS. [PubChem] Structurally, nevirapine belongs to the dipyridodiazepinone chemical class.
    Synonyms
    • 11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one
    • NEV
    • Nevirapine
    • NVP
    • Viramune
    Brand names
    • Viramune
    • Viramune XR
    Affected organism Human Immunodeficiency Virus
    Indication For use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection.
    Pharmacology Nevirapine is a non-nucleoside reverse transcriptase inhibitor (nNRTI) with activity against Human Immunodeficiency Virus Type 1 (HIV-1). HIV-2 RT and eukaryotic DNA polymerases (such as human DNA polymerases alpha, beta, or sigma) are not inhibited by nevirapine. Nevirapine is, in general, only prescribed after the immune system has declined and infections have become evident. It is always taken with at least one other HIV medication such as Retrovir or Videx. The virus can develop resistance to nevirapine if the drug is taken alone, although even if used properly, nevirapine is effective for only a limited time.
    Mechanism of action Nevirapine binds directly to reverse transcriptase (RT) and blocks the RNA-dependent and DNA-dependent DNA polymerase activities by causing a disruption of the enzyme's catalytic site. The activity of nevirapine does not compete with template or nucleoside triphosphates.
    Route of administration Oral
    Categories
    • Anti-HIV Agents
    • Reverse Transcriptase Inhibitors
    ATC-Code J05AG01
    AHFS-Code 08:18.08.16
    CAS number 129618-40-2
     
Ligand Image